The down-regulation of microRNA-328a (miR-328a) in pentylenetetrazole (PTZ)-kindled rats with memory impairment was demonstrated in our previous study, while any contribution of miR-328a to cognitive dysfunction of PTZ-kindled rats remains unknown. In this study we have investigated the effect and the underlying mechanism of miR-328a on the cognitive function in PTZ-kindled rats. 48 SD male rats were divided into 4 groups as follows: a PTZ kindled group, a miR-328a antagomir group, an antagomir-control group, and a sham group (n = 12 for each). All rats except those from the sham group were treated with PTZ 14 times at intervals of 48 h to establish the temporal lobe epilepsy (TLE) models, and miR-328a antagomir was given to the antagomir group as a treatment by lateral-ventricle injection the day after the first injection of PTZ. Morris water maze (MWM) test was performed to assay their learning and memory abilities. The down-regulation of miR-328a in the PTZ group was confirmed using RT-qPCR and the expression of miR-328a was diminished after antagomir treatment (P < 0.05). In the probe test of water maze, the time and distance of the PTZ group were both shorter than those of the sham group (P < 0.05), and those of the antagomir-control group were both longer than those of the antagomir group (P < 0.05). In addition, we found that with the down-regulation of miR-328a, the levels of Beta-site APP-cleaving enzyme (BACE), which is a bioinformatics-predicted target of miR-328a, were up-regulated. These findings suggest that miR-328a may play a role in memory dysfunction in PTZ-kindled rats by regulating the BACE levels and this links the PTZ model with Alzheimer's disease.
Introduction
Epilepsy is known to be a complex clinical syndrome characterized by different types of seizures with or without other specific co-morbid disorders such as cognitive impairment, migraine, depressive disorders, etc. (Bosak et al., 2012; Jabbehdari et al., 2015; Seidenberg et al., 2007) . Memory impairment is one of the most representative neuropsychological disorders in people with TLE (Seidenberg et al., 2007) , and prior studies have experimentally shown that the existence of seizures at an early age causes memory impairment in kainic acid (KA)-induced rat models (Sayin et al., 2004) . Additionally, according to the previous testing in our laboraAbbreviations: miR-328a, microRNA-328a; PTZ, pentylenetetrazole; TLE, temporal lobe epilepsy; MWM, Morris water maze; BACE, beta-site APP-cleaving enzyme; APP, amyloid precursor protein; Abeta, amyloid beta; AD, Alzheimer's disease.
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tory, a decline of memory ability occurred in a definite proportion of rats kindled by pentylenetetrazole (Liu et al., 2015) . There has been evidence that the hippocampus plays a vital role in learning and memory (Bohbot and Corkin, 2007) , while some patients suffering from recurrent epileptic seizures do not show significant structural hippocampal damage in Magnetic Resonance Imaging (MRI) (Holtkamp et al., 2004) . Hence the underlying molecular mechanisms of this prevalent feature among epileptics have aroused a great deal of attention from researchers. Theories of the seizures themselves, as well as antiepileptic drugs (AEDs) have been put forward for the cause of cognitive dysfunction in epilepsy (Onuma, 2011) . Cognitive deficiency is known to be the clinical characteristic of Alzheimer's disease (AD), an age-related neurodegenerative disorder. The primary pathological change in AD is the presence and deposition of amyloid beta (Abeta) peptides in brain, which is the result of proteolytic cleavage reactions, a series of processes, starting with amyloid precursor protein (APP), and mainly catalyzed by the BACE (Dickson, 1997; Vassar et al., 1999 Abeta contributes to the deterioration of cognitive function through participation in oxidative stress (Huang et al., 1999) , restraint of long-term synaptic plasticity (Chen et al., 2000) , electrolyte disturbance via forming the amyloid ion channels (Lal et al., 2007) , etc. Therefore, BACE has been predicted to be a potential therapeutic target for treating AD (Vassar et al., 1999) .
MicroRNAs (miRNAs) are endogenous noncoding RNAs composed of approximately 22 nucleotides and they take a special role in various human diseases by mediating the expression of their target messenger RNAs (mRNAs) which is supposed to be a predominant effect of inhibition through identifying and matching with the 3 -untranslated region of their targets (Guo et al., 2010) . It has been shown that miRNAs could regulate Abeta peptides levels by targeting BACE1 in AD (Boissonneault et al., 2009; Zhu et al., 2012) . Additionally, previous study showed that miR-328a could regulate the expression of BACE1 in mouse with AD (Boissonneault et al., 2009 ). From our previous study, the down-regulation of miR328a in the hippocampus of TLE rats was by miRNA microarray analysis (Liu et al., 2015) . In this study, the learning and memory ability of rats were evaluated using Morris water maze, and RTqPCR was performed to evaluate the expression of miR-328a in the hippocampus. Target genes of miR-328a were predicted using TargetScan, and the expression of the bioinformatics-predicted target was evaluated by western blot assays.
Materials and methods

Animals and grouping
A total of 48 adult male Sprague-Dawley (SD) rats that were 6-7 weeks old and weighed 220-240 g (Animal Experiment Center, Guangxi Medical University, China) were housed under proper conditions (24 ± 2 • C; a 12-h light/dark cycle with lights on at 8:00 a.m.). Fresh food and water were available. All animals were treated appropriately according to the Guide for the Care and Use of Laboratory Animals (National Research Council). Experimental processes were approved by the Guangxi Medical University Animal Experimentation Committee. All reagents used in this study were purchased from commercial suppliers and were of an analytical level requiring further purification. By using a random number table, all rats were grouped as follows: PTZ group, miR-328a antagomir group, antagomir-control group, sham group (n = 12 for each group).
Kindling and lateral-ventricle injection
The TLE model was established by giving the rats intraperitoneal injections of PTZ (Sigma-Aldrich, St. Louis, MO, USA). On the first day, PTZ group, miR-328a antagomir group and antagomircontrol group were given a single intraperitoneal injection of PTZ (60 mg/kg). After the first injection of PTZ, repeat single injections of PTZ (35 mg/kg) were performed 13 times at 48 h intervals. In 30 min after the PTZ administration, rats were considered as TLE models if their behavioral changes reached level IV-V according to the Racine standard (level 0, no change in behavior; level I, chewing; level II, gazing and head nodding; level III, unilateral forelimb clonus, twitching, and scratching; level IV, rearing with bilateral forelimb clonus; level V, widespread muscle spasms, rearing with bilateral forelimb clonus and falling back). Rats in the sham group were injected by the same dose of 0.9% physiological saline instead of PTZ. Lateral-ventricle injections were given to the rats in the miR-328a antagomir group and the antagomir-control group 24 h after their first kindling. Rats anesthetized with 10% chloral hydrate (4 ml/kg) were fixed in a stereotaxic apparatus (Paxinos). The craniotomy was performed with a needle fitted to a 5 ml syringe at the following coordinates: bregma: −0.8 mm; laterality: 1.3 mm; depth: 3.7 mm. Then, each rat from the miR-328a antagomir group was given a single intracerebroventricular injection of rno-miR328a antagomir (Guangzhou Ruibo Biological Technology Co. Ltd.) and rats from the antagomir-control group were given antagomir control (Guangzhou Ruibo Biological Technology Co. Ltd.). The dose of the antagomir is 4 nmol, and the total volume for each rat is 10 ul.
Morris water maze test
The spatial learning and memory ability of rats were tested and analyzed using the Morris water maze (Panlab, Barcelona, Spain). Ink was added in order to make the platform invisible. Reference items were placed around the pool so that the rats could use them for spatial orientation and remained unchanged during the experimental period. The data were produced by SLY-WMS MWM system v. 2.1.
The four-trial-per-day training of rats in the water maze that lasted for five consecutive days was conducted 24 h after the last injection of PTZ. A maximum time of 90 s was available for each experimental rat to find the hidden platform underwater. Each trial had a different starting point, and if they failed to find the platform in 90 s, the rats would be guided to the platform manually and kept at the platform for 10 s. The time spent by each rat to reach the platform (i.e., the escape latency period) was recorded, 90 s at most.
Spatial probe test was conducted on the sixth day. The entire test lasted for 90 s. The platform was removed and each rat was released opposite the target quadrant (the southeast quadrant), facing the wall of the pool. In the probe test, time and distance that rats spent in the target quadrant were recorded to assess their spatial memory ability.
Tissue dissection and reverse transcription-qPCR for miR-328a
The hippocampal tissue was harvested and stored as previously described (Liu et al., 2015) . Total RNA was extracted with TRIzol ® (Invitrogen Life Technologies, USA), and the quantity was measured with the NanoDrop ® ND-1000 spectrophotometer. Reverse transcription was performed in accordance with the specification of Mir-X TM miRNA First-Strand Synthesis kit (Takara, Dalian, China), using Gene Amp PCR System 9700 (Applied Biosystems) at 16 • C for 30 min, 42 • C for 40 min, and 85 • C for 5 min. PCR reactions were performed with Mir-X miRNA qRT-PCR SYBR Kit (Takara, Dalian, China), using Light Cycler 480 Real-time PCR(12.5 l 2x SYBR Advantage premix, 0.5 l 50x ROX Dye, 0.5 l 10 M miRNAspecific Primer, 0.5 l mRQ 3 Primer, 2.0 l of template cDNA, and 9 l RNase-free H2O to 25 l in total) at 95 • C for 10 s, 40 cycles of 95 • C for 5 s and 60 • C for 20 s, followed by 95 • C for 60 s, and 55 • C for 30 s. The specific primer for miR-328a was designed and produced by Dalian biotethnology Co. Ltd. Dalian Takara (Dalian, China), and U6 was used as the internal control. The relative expression quantity of miR-328a was calculated using relative values of cycle threshold (CT) normalized to that of U6 as 2 − CT ( Ct = C samples − Ct meanvalueofsamplesfromtheshamgroup ).
Target gene prediction and western blotting analysis
Target genes of miR-328a were predicted by the application of bioinformatics analysis (TargetScan), and those that might take a role in cognitive dysfunction were selected for further study. The expressions of BACE in hippocampi from all experimental rats were investigated using Western blotting. The hippocampal tissues were homogenized in an ice-cold mixture of RIPA buffer (Beyotime, Haimen, China) and protease inhibitors, and then incubated over ice for 30 min. After the centrifugation, the supernatant of the homogenates was collected, and the concentration of total protein was detected by BCA Protein Assay kit. Samples containing an equal quantity of denatured protein (50 g) were loaded, and were then electrophoresed in 10% SDS-PAGE, followed by electrophoretic transference onto 0.45 mm PVDF membranes (Millipore Corp, Bellerica, Massachusetts) by the method of semi-dry transfer. Membranes with proteins were blocked with 5% skim milk and TRIS buffered saline plus Tween 20 (TBST: 20 mM Tris/HCl, 150 mM NaCl, 0.1% Tween 20, pH 7.4) solution for 1 h at room temperature, and then incubated with monoclonal mouse anti-BACE antibody (1:600; Santa Cruz Blotechnology, CA, USA) or rabbit antibody against GAPDH (1:3000, Cell Signaling Technology, USA) overnight at 4 • C. After 10min-wash for 3 times in TBST, membranes were then incubated with secondary anti-mouse antibody (1:5000, Cell Signaling Technology, USA) or secondary anti-rabbit antibody (1:10,000, Cell Signaling Technology, USA) for 1 h at surrounding temperature. Signals were detected using LI-COR Odyssey imaging system (LI-COR Biosciences, USA) in 800 nm channel, and the density of each immunoreactive band normalized to corresponding GAPDH was measured using the LI-COR Odyssey analysis software.
Statistical analysis
All results are presented as the mean ± standard deviation (SD). Data in this study, including the escape latency on day 5, the time and distance in the target quadrant on day 6 in the MWM test, the comparative cycle threshold in RT-qPCR, and the comparative density of immunoreactive bands in Western blot were analyzed by one-way ANOVA and the LSD test with SPSS 17.0 package (Chicago, IL, USA). Differences among groups were considered statistically significant only if the value of P < 0.05 (ANOVA).
Results
PTZ kindling
After the PTZ administration, rats with the behavioral changes reaching levels IV-V of the Racine standard were considered as TLE models (n = 36). After the assessment of memory behavior by the MWM test, half of the rats were randomly selected from each group and were sacrificed for RT-qPCR while the other half was evaluated by Western blotting analysis.
Morris water maze test
The escape latency of all the 4 groups lessened progressively during 5 training days (Fig. 1A) . The escape latency on the 5th day, the swimming distance and the time that rats spent in the target quadrant were all analyzed to determine the differentials of the spatial memory ability among the 4 groups. As shown in Fig. 1A , compared to the sham group (16.02 ± 6.79 s), the 5th-day latency of the PTZ group (25.47 ± 9.81 s) was longer (P < 0.05). There were no statistical differences between the PTZ group and antagomircontrol group (24.48 ± 5.73 s, P > 0.05). Latency of the antagomir group on the 5th day (34.10 ± 11.77 s) was longer than that of the antagomir-control group (P < 0.05).
In the Spatial probe test, the platform was removed. As shown in Fig. 1B and 1C , compared to the sham group (39.64 ± 9.22 s), the time that the PTZ group (32.40 ± 8.86 s) spent in the target quadrant (SE) was shorter (P < 0.05). There was no statistical difference between the PTZ group and antagomir-control group (31.89 ± 6.98 s, P > 0.05). The time that the antagomir group (24.16 ± 6.64 s) spent in SE was shorter than that of the antagomir-control group (P < 0.05). Compared to the sham group (596.60 ± 151.48 cm), the distance that the PTZ group (472.91 ± 96.48 cm) swam in SE was shorter (P < 0.05). There were no statistical differences between the PTZ group and antagomircontrol group (494.70 ± 99.81 cm, P > 0.05). The distance that the antagomir group (368.60 ± 114.74 cm) swam in SE was shorter than that of the antagomir-control group (P < 0.05). The representative pathways of rats from 4 groups in the probe test are shown in Fig. 1D . Rats from the antagomir group could hardly locate the target quadrant correctly. The data indicated that there was memory impairment in PTZ-kindled rats, and giving them the miR-328a antagomir could further impair the memory ability in PTZ-kindled rats.
RT-qPCR for miR-328a and target gene prediction
As shown in Fig. 2A , miR-328a levels in the hippocampus of rats from the sham group (2 − CT = 1.03 ± 0.29) were higher than those from the PTZ group (2 − CT = 0.74 ± 0.20, P < 0.05), which is consistent with the previous study (Liu et al., 2015) . There was no significant statistical difference between the PTZ group and the antagomir-control group (2 − CT = 0.73 ± 0.29, P > 0.05). Additionally, the miR-328a levels of the antagomir-control group were higher than those from the antagomir group (2 − CT = 0.43 ± 0.14, P < 0.05). The data indicated that the expression of miR-328a was down-regulated in PTZ-kindled rats, and giving them the miR-328a antagomir could further decrease the miR-328a levels.
The downstream gene of miR-328a was predicted using TargetScan. BACE1, SYNGAP1, GTPBP2 and BCL9L, etc. were predicted to be the potential downstream gene. As shown in Fig. 2B , miR-328a has conserved and strong binding sites on the position 408-415 nt of the BACE1 3 untranslated region (UTR).
Western blotting analysis for the expression of BACE in the hippocampus
Western blotting was performed to determine the expression of BACE in the hippocampus and to assess the differences among the 4 groups. As shown in Fig. 3A , compared to the sham group, the expression of BACE of the PTZ group was up-regulated, and that of the antagomir group was higher than that of the antagomircontrol group. Fig. 3B showed that the expression of BACE of the PTZ group increased 0.65-fold over that of the sham group, and the expression of the antagomir group increased 0.38-fold over that of the antagomir-control group. There was no significant statistical difference between the PTZ group and the antagomir-control group (P > 0.05). The data indicated that the expression of BACE was up-regulated in PTZ-kindled rats, and the down-regulation of miR-328a could further increase the BACE levels.
Conclusion
The expression of miR-328a in PTZ-kindled rats was downregulated. MiR-328a could regulate the cognitive function of rats. The down-regulation of miR-328a contributed to the cognitive dysfunction of PTZ-kindled rats by up-regulating the BACE levels and this linked the PTZ model with Alzheimer's disease.
Discussion
A novel factor that contributes to the cognitive dysfunction in TLE
A large proportion of TLE patients is suffers from varying levels of cognitive deficit including learning and memory impairment (Seidenberg et al., 2007) . However, the underlying mechanism of this prevalent phenomenon is vague. Previous studies have shown that this feature of epilepsy may relate to the seizures themselves or AEDs, etc. (Majak and Pitkanen, 2004; Onuma, 2011) . Our earlier study was the first attempt to reveal and explain this phenomenon through detecting the changes of hippocampal microRNAs. As the result of miRNA microarray analysis of TLE rats with memory impairment, 4 microRNAs showed up-regulation (miR-34c, miR-181a, miR-374, and miR-let-7c-1), and 7 microRNAs showed down-regulation (miR-127-5p, miR-328a, miR-331, miR-375, miR-770-5p, miR-1188, and miR-873-5p) (Liu et al., 2015) . Whether these variations contribute to the cognitive dysfunction remains unknown. The decrease of miR-328a was confirmed using RT-qPCR in this study. After the miR-328a antagomir administration, the learning and memory ablity of the TLE rats were impaired, which indicated that miR-328a might regulate cognitive function in TLE.
6.2. A molecular pathway that might work both in Alzheimer' disease and epilepsy AD is known as an age-related neurodegenerative disorder characterized by cognitive dysfunction. Over the last few decades, the relationship between AD and epilepsy, especially TLE, has attracted great attention due to some shared physical, cognitive and mental manifestation. In early studies, recurrent spontaneous seizures were considered as the consequence of AD because the occurrence rate of seizures in people with AD is much higher than that in regular populations. Additionally, different types of seizures occurred in people with AD indicating that the electrical discharges in the brain were somehow triggered in the development of AD (Larner, 2010; Palop and Mucke, 2009; Rao et al., 2009) . Interestingly, studies of transgenic AD mice showed that before the Abeta peptides accumulated, the epileptic seizures had occurred several times already. In addition, the transgenic AD mice did not appear to suffer from significant seizures without the accumulation of Abeta peptides (Palop et al., 2007; Roberson et al., 2011) . These results indicated that as AD developed, the occurrence of epilepsy might play an assistant role in the production and accumulation of amyloid beta peptides. However, the underlying mechanism of this effect remains unclear. The results shown in this study suggested that part of the molecular pathway in AD might also work in epilepsy. As the beta-secretase of APP, the BACE levels will significantly affect the development of AD, and that makes BACE a potential target of the treatment of AD (Vassar et al., 1999) . Thus, the cognitive dysfunction and the downregulation of miR-328a plus the up-regulation of BACE link the PTZ model with Alzheimer's disease.
Orientation of future research
As shown in a previous study, miR-328 was found to be downregulated in APPSwe/PS1 mice, and effectively regulating the BACE levels (Boissonneault et al., 2009) , which is consistent with the results of our study. Just as we find increasing expression levels and enzymatic activity of BACE in the development of AD (Yang et al., 2003) , with the prolongation of time, epilepsy might finally develop into an Abeta-accumulation situation in a similar way. Therefore, the pathological changes in brains, especially the expression levels and morphology changes of Abeta peptides in patients with TLE should be paid more attention in the further research. To study how the brains of epileptics will develop, the detection of Abeta peptides levels on the basis of the establishment of long-term TLE rat models is necessary. Furthermore, as presented in previous studies, the cause of cognitive dysfunction in epilepsy is primarily the seizures themselves (Majak and Pitkanen, 2004) , so regular medication dealing with the seizures was also considered to take care of the cognitive dysfunction. Interestingly, in recent studies, some AEDs like levetiracetam and some sodium channel blocking AEDs can play a positive role in AD (Bakker et al., 2012; Ziyatdinova et al., 2011) . As a result, drugs contributing to the improvement of both epilepsy and AD are drawing more and more attention. In conclusion, besides the regular therapy of epilepsy, there are deeper studies required to be done dealing with the cognitive deficiency, like the role that miR-328a plays in TLE.
